Reata announces patient enrollment in clinal trial of Bardoxolone Methyl

Reata Pharmaceuticals, a clinical-stage biopharmaceutical company recently announced enrollment of first patient in the Phase 3 FALCON trial of bardoxolone in patients with ADPKD (autosomal dominant polycystic kidney disease), cites source.....

BioTheryX bags FDA approval for acute myeloid leukemia treatment drug

The company expects enrollment of Phase I Trial during the third quarter of 2019. U.S. biotechnology firm, BioTheryX, Inc. has recently announced that the the U.S. Food and Drug Administration (FDA) has approved its investigational ne....

NetApp, NVIDIA join forces to develop AI Centre of Excellence in India

It will help partners and customers who are looking for AI deployment as a part of their transformation journey NVIDIA, the graphics processing unit designer and NetApp, a data management service provider, have reportedly announced a partn....

BioMarin’s hemophilia gene therapy seeks approval in U.S & Europe

BioMarin Pharmaceutical Inc.’s experimental gene therapy, valoctocogene roxaparvovec, targeting severe hemophilia A in adults has reportedly met pre-specified clinical criteria to seek regulatory review in the U.S. and Europe.  ....

Victory Metals initiates Phase II drill program at Iron Point Project

The program will include drilling 49 holes using one diamond drill rig and two reverse circulation (RC) rigs. Vancouver-based Victory Metals Inc. has recently announced the launch of a 10,000-metre drilling program at its Iron Point Vanadi....

Reprieve Cardiovascular reveals late-breaking AHF clinical trial data

The trials were set to determine the Reprieve-Guided Diuretic Therapy system’s ability to achieve safe net volume reduction while alleviating related symptoms in ADHF patients. Reprieve Cardiovascular™, one of the leading medic....

AzurRx’s Phase II OPTION study of MS1819-SD achieves enrollment target

It has reached the enrollment target of 30-35 patients that was determined when the OPTION study was started in December 2018 AzurRx BioPharma has recently confirmed that it has achieved its enrollment target of 30-35 patients in the ongoi....

Lilly’s low-cost insulin lispro hits shelves despite price disputes

Pharmaceutical major Eli Lilly has officially launched an inexpensive generic version of the insulin drug Humalog, reports of which made way to the headlines in March. If sources are to be believed, the launch has come on the heels of the o....

Tocagen continues with Toca 5 Phase 3 trial in brain cancer patients

The trial is being conducted in patients with recurrent high-grade glioma An Independent Data Monitoring Committee recommended the study continue without modification Reports confirm that Tocagen Inc, a clinical-stage and cancer-selective....

Alembic Pharma gets FDA approval for Solifenacin Succinate tablets

The FDA approval was awarded to Solifenacin Succinate tablets’ abbreviated new drug application (ANDA). The pharmaceutical firm now holds a total of 94 ANDA approvals from the US health regulator. Alembic Pharmaceuticals Ltd., (A....

Our Contributors

$row3->name
Mateen Dalal
$row3->name
Akshay Kedari
« First8283848586